Technology Search Results

A collaborative effort between researchers at Virginia Tech and Virginia Commonwealth Universities has led to the development of a novel approach for the targeted delivery of imaging and therapeutic agents.

It is well known that the IL-13 Ra2 cell receptor is over-expressed in brain tumors. An IL-13 peptide, known to ...

A novel approach to present highly conserved antigenic peptides in a vaccine formulation such that broad, cross-protective immune responses to heterotypic strains of influenza virus are elicited. The approach would have applicability in both inactivated vaccine and live attenuated vaccine formulations.

Formulations could be used for parenteral or mucosal vaccine ...

Antithrombotic drugs often fail in the long run due to the emergence of significant compliance and safety issues, including increased bleeding. Thus, a new technology developed at Virginia Tech is unique in that it targets a specific macromolecule that is released in response to platelet activation but otherwise remains ...

The invention is a technique to treat tumors with great precision while selectively treating infiltrative cells beyond the tumor margin. This technique is considerably better than current focal ablation techniques in that it is more controllable, accurate and less invasive than traditional techniques. Furthermore, the therapy does not ...

The invention includes methods and compositions that prevent pathogen virulence proteins from entering into plant or animal cells, including humans, thus providing a novel mechanism for protection from infection.